Education
About Us
Working with TipRanks
Follow Us
Bio-Path Holdings (BPTH)
OTHER OTC:BPTH
Total Valuation
Bio-Path Holdings has a market cap or net worth of $1.66M. The enterprise value is $1.73M.
Market Cap$1.66M
Enterprise Value$1.73M
Share Statistics
Bio-Path Holdings has 8,307,892 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,307,892
Owned by Insiders81.83%
Owned by Institutions3.04%
Financial Efficiency
Bio-Path Holdings’s return on equity (ROE) is -64.25 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)-64.25
Return on Assets (ROA)-2.55
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee0.00
Profits Per Employee-989.40K
Employee Count10
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Bio-Path Holdings is -0.28. Bio-Path Holdings’s PEG ratio is >-0.01.
PE Ratio-0.28
PS Ratio0.00
PB Ratio-0.50
Price to Fair Value18.09
Price to FCF-0.14
Price to Operating Cash Flow-0.12
PEG Ratio>-0.01
Income Statement
In the last 12 months, Bio-Path Holdings had revenue of 0.00 and earned -9.89M in profits. Earnings per share was -4.12.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income-9.89M
Net Income-9.89M
EBITDA0.00
Earnings Per Share (EPS)-4.12
Cash Flow
In the last 12 months, operating cash flow was -10.85M and capital expenditures 0.00, giving a free cash flow of -10.85M billion.
Operating Cash Flow-10.85M
Free Cash Flow-10.85M
Free Cash Flow per Share-1.31
Dividends & Yields
Bio-Path Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.89
52-Week Price Change-91.98%
50-Day Moving Average0.16
200-Day Moving Average0.71
Relative Strength Index (RSI)48.82
Average Volume (3m)25.44K
Important Dates
Bio-Path Holdings upcoming earnings date is Aug 19, 2025, TBA Not Confirmed.
Last Earnings DateMay 15, 2025
Next Earnings DateAug 19, 2025
Ex-Dividend Date―
Financial Position
Bio-Path Holdings as a current ratio of 1.15, with Debt / Equity ratio of -12.17%
Current Ratio1.15
Quick Ratio1.15
Debt to Market Cap0.03
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Bio-Path Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Bio-Path Holdings EV to EBITDA ratio is 0.00, with an EV/FCF ratio of -0.16.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow-0.16
EV to Operating Cash Flow-0.16
Balance Sheet
Bio-Path Holdings has $122.00K in cash and marketable securities with $315.00K in debt, giving a net cash position of $193.00K billion.
Cash & Marketable Securities$122.00K
Total Debt$315.00K
Net Cash$193.00K
Net Cash Per Share$0.02
Tangible Book Value Per Share$0.06
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Bio-Path Holdings is $9.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$9.00
Price Target Upside5194.12% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast79.79%